The Potential for Added Benefits with β-Blockers and Calcium Antagonists in Treating Cardiovascular Disorders W. G. Nayler Section 1: Hypertension 18 October 2012 Pages: 1 - 8
Future Approaches to the Treatment of Hypertension in the Light of Results from Recent Trials S. G. Ball Section 1: Hypertension 18 October 2012 Pages: 9 - 15
Aims of Combination Therapy — Improved Quality of Life or Better Blood Pressure Control? D. Maclean Section 1: Hypertension 18 October 2012 Pages: 16 - 21
Atenolol and Sustained Release Nifedipine Alone and in Combination in Hypertension A Randomised, Double-Blind, Crossover Study J. L. AndertonB. D. VallanceW. H. Perks Section 1: Hypertension 18 October 2012 Pages: 22 - 26
Treatment of Hypertension with a Combination of Nifedipine and Atenolol Compared with Atenolol Alone H. KöhlerEuropean Multicentre Study Group Section 1: Hypertension 18 October 2012 Pages: 27 - 28
Efficacy and Tolerability of Atenolol, Nifedipine and Their Combination in the Management of Hypertension N. N. StanleyJ. L. ThirkettleI. D. Heath Section 1: Hypertension 18 October 2012 Pages: 29 - 35
Tolerability, Safety and Dosage of a Fixed Combination of Sustained Release Nifedipine Plus Atenolol D. I. Rees-Jones Section 1: Hypertension 18 October 2012 Pages: 36 - 38
Regression of Left Ventricular Hypertrophy during Combined Atenolol and Nifedipine Treatment I.-W. FranzU. TönnesmannR. Ketelhut Section 1: Hypertension 18 October 2012 Pages: 39 - 43
β-Blockers and Calcium Antagonists in Angina Pectoris H. J. Dargie Section 2: Ischaemic Heart Disease 18 October 2012 Pages: 44 - 50
Atenolol with and without Nifedipine in the Treatment of Angina Pectoris M. SandbergR. A. Foale Section 2: Ischaemic Heart Disease 18 October 2012 Pages: 51 - 55
